Venmax Drugs & Pharmaceuticals Ltd.BSE: VENMAX

Regulation 31(4) - SAST Disclosure

· Issued by Venmax Drugs & Pharmaceuticals Ltd. via BSE India

Filed with BSE · · 2 pages · English

Subject: Disclosure under Regulation 31(4) of SEBI (SAST) Regulations, 2011 Please find enclosed herewith the annual declaration received from the Promoters/Promoter Group of the Company under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2026. The Promoters/Promoter Group have confirmed that they have not ma

Venmax Drugs & Pharmaceuticals Ltd. on 6ix

Earlier from Venmax Drugs & Pharmaceuticals

Later from Venmax Drugs & Pharmaceuticals

All Venmax Drugs & Pharmaceuticals news releases